The use of transcriptomic biomarkers for personalized medicine

Bettina Heidecker, Joshua Hare

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Microarrays are a high throughput technology that allows the quantification of tens of thousands of RNA transcripts in a single reaction. This new technology offers the promise of comprehensive study of disease at a genomic level, potentially identifying novel molecular abnormalities, developing novel clinical biomarkers, and investigating drug efficacy. The ability to develop a molecular profile corresponding to a therapeutic effect is the basis for the concept of drug repositioning. With regard to prediction of clinical events, microarray technology has the potential to contribute to the development of sophisticated new biomarkers useful as predictors of disease etiology, outcome, and responsiveness to therapy'so-called personalized medicine. Currently progress in the field is hampered by a degree of skepticism about the reliability of microarray data and its relevance for clinical applications. Here we discuss possible pitfalls of transcriptomic analysis, review current developments in the cardiovascular area and address the use of transcriptomics for clinical applications.

Original languageEnglish
Pages (from-to)1-11
Number of pages11
JournalHeart Failure Reviews
Volume12
Issue number1
DOIs
StatePublished - Mar 1 2007

Fingerprint

Precision Medicine
Biomarkers
Technology
Drug Repositioning
Therapeutic Uses
RNA
Pharmaceutical Preparations
Therapeutics

Keywords

  • Biomarker
  • Microarray
  • Molecular signature
  • Pharmacogenomics
  • Transcriptome

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The use of transcriptomic biomarkers for personalized medicine. / Heidecker, Bettina; Hare, Joshua.

In: Heart Failure Reviews, Vol. 12, No. 1, 01.03.2007, p. 1-11.

Research output: Contribution to journalArticle

@article{8979960735d34d2ea0fb7628c0b5ef80,
title = "The use of transcriptomic biomarkers for personalized medicine",
abstract = "Microarrays are a high throughput technology that allows the quantification of tens of thousands of RNA transcripts in a single reaction. This new technology offers the promise of comprehensive study of disease at a genomic level, potentially identifying novel molecular abnormalities, developing novel clinical biomarkers, and investigating drug efficacy. The ability to develop a molecular profile corresponding to a therapeutic effect is the basis for the concept of drug repositioning. With regard to prediction of clinical events, microarray technology has the potential to contribute to the development of sophisticated new biomarkers useful as predictors of disease etiology, outcome, and responsiveness to therapy'so-called personalized medicine. Currently progress in the field is hampered by a degree of skepticism about the reliability of microarray data and its relevance for clinical applications. Here we discuss possible pitfalls of transcriptomic analysis, review current developments in the cardiovascular area and address the use of transcriptomics for clinical applications.",
keywords = "Biomarker, Microarray, Molecular signature, Pharmacogenomics, Transcriptome",
author = "Bettina Heidecker and Joshua Hare",
year = "2007",
month = "3",
day = "1",
doi = "10.1007/s10741-007-9004-7",
language = "English",
volume = "12",
pages = "1--11",
journal = "Heart Failure Reviews",
issn = "1382-4147",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - The use of transcriptomic biomarkers for personalized medicine

AU - Heidecker, Bettina

AU - Hare, Joshua

PY - 2007/3/1

Y1 - 2007/3/1

N2 - Microarrays are a high throughput technology that allows the quantification of tens of thousands of RNA transcripts in a single reaction. This new technology offers the promise of comprehensive study of disease at a genomic level, potentially identifying novel molecular abnormalities, developing novel clinical biomarkers, and investigating drug efficacy. The ability to develop a molecular profile corresponding to a therapeutic effect is the basis for the concept of drug repositioning. With regard to prediction of clinical events, microarray technology has the potential to contribute to the development of sophisticated new biomarkers useful as predictors of disease etiology, outcome, and responsiveness to therapy'so-called personalized medicine. Currently progress in the field is hampered by a degree of skepticism about the reliability of microarray data and its relevance for clinical applications. Here we discuss possible pitfalls of transcriptomic analysis, review current developments in the cardiovascular area and address the use of transcriptomics for clinical applications.

AB - Microarrays are a high throughput technology that allows the quantification of tens of thousands of RNA transcripts in a single reaction. This new technology offers the promise of comprehensive study of disease at a genomic level, potentially identifying novel molecular abnormalities, developing novel clinical biomarkers, and investigating drug efficacy. The ability to develop a molecular profile corresponding to a therapeutic effect is the basis for the concept of drug repositioning. With regard to prediction of clinical events, microarray technology has the potential to contribute to the development of sophisticated new biomarkers useful as predictors of disease etiology, outcome, and responsiveness to therapy'so-called personalized medicine. Currently progress in the field is hampered by a degree of skepticism about the reliability of microarray data and its relevance for clinical applications. Here we discuss possible pitfalls of transcriptomic analysis, review current developments in the cardiovascular area and address the use of transcriptomics for clinical applications.

KW - Biomarker

KW - Microarray

KW - Molecular signature

KW - Pharmacogenomics

KW - Transcriptome

UR - http://www.scopus.com/inward/record.url?scp=34247366346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247366346&partnerID=8YFLogxK

U2 - 10.1007/s10741-007-9004-7

DO - 10.1007/s10741-007-9004-7

M3 - Article

C2 - 17393305

AN - SCOPUS:34247366346

VL - 12

SP - 1

EP - 11

JO - Heart Failure Reviews

JF - Heart Failure Reviews

SN - 1382-4147

IS - 1

ER -